Bio-Rad Laboratories-ABIO
ASignal's systematic analysis rates BIO as Neutral.
Reflects the latest available analysis · analyzed Aug 24, 2026
The case on BIO
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- MACD above signal line with expanding histogram, indicating strengthening uptrend
- Price trading above 20-day and 50-day moving averages (SMA20: 351.08, SMA50: 317.72)
- Healthy free cash flow of $283.19M supports operational stability
- Low debt-to-equity ratio of 0.19x indicates strong financial health
- Gross margin of 52.04% reflects strong pricing power in Medical Devices sector
- RSI at 81.13 indicates overbought conditions, increasing risk of near-term pullback
- Price approaching upper Bollinger Band (386.06), suggesting limited upside in short term
- Negative revenue growth YoY (-0.10%), indicating stagnation in top-line expansion
- Low return on equity (3.11%) despite high financial health score
- Earnings growth (18.70%) not fully supported by revenue growth, raising sustainability concerns
- PEG ratio of 4.01x suggests significant overvaluation relative to growth potential
See the full verdict on BIO
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes BIO
Most investors never get a second opinion, let alone several. ASignal runs BIO past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.